BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15942677)

  • 21. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).
    Gigante M; Pontrelli P; Montemurno E; Roca L; Aucella F; Penza R; Caridi G; Ranieri E; Ghiggeri GM; Gesualdo L
    Nephrol Dial Transplant; 2009 Jun; 24(6):1858-64. PubMed ID: 19131354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
    Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
    PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.
    Babayeva S; Miller M; Zilber Y; El Kares R; Bernard C; Bitzan M; Goodyer P; Torban E
    Pediatr Nephrol; 2011 Jul; 26(7):1071-81. PubMed ID: 21380797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Permeability factors in focal segmental glomerulosclerosis.
    Savin VJ; McCarthy ET; Sharma M
    Semin Nephrol; 2003 Mar; 23(2):147-60. PubMed ID: 12704575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic basis of nephrotic syndrome--review.
    Obeidová H; Merta M; Reiterová J; Maixnerová D; Stekrová J; Rysavá R; Tesar V
    Prague Med Rep; 2006; 107(1):5-16. PubMed ID: 16752799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral permeability factors in the nephrotic syndrome: a compendium and prospectus.
    Musante L; Candiano G; Zennaro C; Bruschi M; Carraro M; Artero M; Ghiggeri GM
    J Nephrol; 2001; 14 Suppl 4():S48-50. PubMed ID: 11798145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetic basis of FSGS and steroid-resistant nephrosis.
    Pollak MR
    Semin Nephrol; 2003 Mar; 23(2):141-6. PubMed ID: 12704574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apheresis in primary focal segmental glomerulosclerosis of native and transplanted kidneys: a therapeutic protocol.
    Moriconi L; Passalacqua S; Pretagostini R; Battaglia G; Russo G; De Palo T; Rindi P; Puccini R; Batini V; Carraro M; Faccini L; Artero M; Zennaro C; Cristofani R
    J Nephrol; 2000; 13(5):347-51. PubMed ID: 11063138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
    Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis.
    Szeto CC; Wang G; Chow KM; Lai FM; Ma TK; Kwan BC; Luk CC; Li PK
    Clin Nephrol; 2015 Oct; 84(4):198-205. PubMed ID: 26308082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases.
    Ikezumi Y; Suzuki T; Karasawa T; Kawachi H; Nikolic-Paterson DJ; Uchiyama M
    Biochem Biophys Res Commun; 2008 Nov; 376(4):706-11. PubMed ID: 18809387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis.
    Monteiro EJ; Pereira AC; Pereira AB; Krieger JE; Mastroianni-Kirsztajn G
    J Nephrol; 2006; 19(3):366-71. PubMed ID: 16874699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
    Sakurai N; Kuroiwa T; Ikeuchi H; Hiramatsu N; Takeuchi S; Tomioka M; Shigehara T; Maeshima A; Kaneko Y; Hiromura K; Kopp JB; Nojima Y
    Nephrol Dial Transplant; 2009 Aug; 24(8):2378-83. PubMed ID: 19188342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
    Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
    Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.
    Furue T; Hattori M; Tsukaguchi H; Kitamura A; Oomori T; Ogino D; Nakakura H; Ashida A; Miura K; Hisano M; Takahashi K; Chikamoto H; Akioka Y; Sakano T
    Pediatr Transplant; 2008 May; 12(3):341-6. PubMed ID: 18208440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
    Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
    Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.
    Doublier S; Ruotsalainen V; Salvidio G; Lupia E; Biancone L; Conaldi PG; Reponen P; Tryggvason K; Camussi G
    Am J Pathol; 2001 May; 158(5):1723-31. PubMed ID: 11337370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli.
    McCarthy ET; Sharma M; Sharma R; Falk RJ; Jennette JC
    J Lab Clin Med; 2004 Apr; 143(4):225-9. PubMed ID: 15085081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.